Cargando…

Immobilization of Metronidazole on Mesoporous Silica Materials

Metronidazole (MTZ) is a widely used drug, but due to its many side effects, there is a growing trend today to use a minimum dose while maintaining high efficacy. One way to meet this demand is to reduce the size of the drug particles. A relatively new method of size reduction is attaching the drug...

Descripción completa

Detalles Bibliográficos
Autores principales: Szentmihályi, Klára, Klébert, Szilvia, May, Zoltán, Bódis, Eszter, Mohai, Miklós, Trif, László, Feczkó, Tivadar, Károly, Zoltán
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699156/
https://www.ncbi.nlm.nih.gov/pubmed/36365150
http://dx.doi.org/10.3390/pharmaceutics14112332
_version_ 1784839002081198080
author Szentmihályi, Klára
Klébert, Szilvia
May, Zoltán
Bódis, Eszter
Mohai, Miklós
Trif, László
Feczkó, Tivadar
Károly, Zoltán
author_facet Szentmihályi, Klára
Klébert, Szilvia
May, Zoltán
Bódis, Eszter
Mohai, Miklós
Trif, László
Feczkó, Tivadar
Károly, Zoltán
author_sort Szentmihályi, Klára
collection PubMed
description Metronidazole (MTZ) is a widely used drug, but due to its many side effects, there is a growing trend today to use a minimum dose while maintaining high efficacy. One way to meet this demand is to reduce the size of the drug particles. A relatively new method of size reduction is attaching the drug molecules to a mesoporous carrier. In this paper, we studied the fixation of MTZ molecules on mesoporous silica carriers. The drug was immobilized on two mesoporous silica materials (Syloid, SBA-15) with the use of a variety of immersion techniques and solvents. The immobilized drug was subjected to physicochemical examinations (e.g., SEM, XPS, XRD, nitrogen uptake, DSC) and dissolution studies. A significantly higher immobilization was attained on SBA-15 than on a Syloid carrier. Among the processing parameters, the type of MTZ solvent had the highest influence on immobilization. Ultrasonic agitation had a lower but still significant impact, while the concentration of MTZ in the solution made no difference. Under optimal conditions, with the application of an ethyl acetate solution, the surface coverage on SBA-15 reached as much as 91%. The immobilized MTZ exhibited a ca. 10% faster dissolution rate as compared to the pure micron-sized drug particles.
format Online
Article
Text
id pubmed-9699156
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96991562022-11-26 Immobilization of Metronidazole on Mesoporous Silica Materials Szentmihályi, Klára Klébert, Szilvia May, Zoltán Bódis, Eszter Mohai, Miklós Trif, László Feczkó, Tivadar Károly, Zoltán Pharmaceutics Article Metronidazole (MTZ) is a widely used drug, but due to its many side effects, there is a growing trend today to use a minimum dose while maintaining high efficacy. One way to meet this demand is to reduce the size of the drug particles. A relatively new method of size reduction is attaching the drug molecules to a mesoporous carrier. In this paper, we studied the fixation of MTZ molecules on mesoporous silica carriers. The drug was immobilized on two mesoporous silica materials (Syloid, SBA-15) with the use of a variety of immersion techniques and solvents. The immobilized drug was subjected to physicochemical examinations (e.g., SEM, XPS, XRD, nitrogen uptake, DSC) and dissolution studies. A significantly higher immobilization was attained on SBA-15 than on a Syloid carrier. Among the processing parameters, the type of MTZ solvent had the highest influence on immobilization. Ultrasonic agitation had a lower but still significant impact, while the concentration of MTZ in the solution made no difference. Under optimal conditions, with the application of an ethyl acetate solution, the surface coverage on SBA-15 reached as much as 91%. The immobilized MTZ exhibited a ca. 10% faster dissolution rate as compared to the pure micron-sized drug particles. MDPI 2022-10-29 /pmc/articles/PMC9699156/ /pubmed/36365150 http://dx.doi.org/10.3390/pharmaceutics14112332 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Szentmihályi, Klára
Klébert, Szilvia
May, Zoltán
Bódis, Eszter
Mohai, Miklós
Trif, László
Feczkó, Tivadar
Károly, Zoltán
Immobilization of Metronidazole on Mesoporous Silica Materials
title Immobilization of Metronidazole on Mesoporous Silica Materials
title_full Immobilization of Metronidazole on Mesoporous Silica Materials
title_fullStr Immobilization of Metronidazole on Mesoporous Silica Materials
title_full_unstemmed Immobilization of Metronidazole on Mesoporous Silica Materials
title_short Immobilization of Metronidazole on Mesoporous Silica Materials
title_sort immobilization of metronidazole on mesoporous silica materials
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699156/
https://www.ncbi.nlm.nih.gov/pubmed/36365150
http://dx.doi.org/10.3390/pharmaceutics14112332
work_keys_str_mv AT szentmihalyiklara immobilizationofmetronidazoleonmesoporoussilicamaterials
AT klebertszilvia immobilizationofmetronidazoleonmesoporoussilicamaterials
AT mayzoltan immobilizationofmetronidazoleonmesoporoussilicamaterials
AT bodiseszter immobilizationofmetronidazoleonmesoporoussilicamaterials
AT mohaimiklos immobilizationofmetronidazoleonmesoporoussilicamaterials
AT triflaszlo immobilizationofmetronidazoleonmesoporoussilicamaterials
AT feczkotivadar immobilizationofmetronidazoleonmesoporoussilicamaterials
AT karolyzoltan immobilizationofmetronidazoleonmesoporoussilicamaterials